23andMe CEO Anne Wojcicki is attempting to buy her company back for a mere $42 million. It’s a fraction of the company’s former value: Just four years ago, the DNA testing company was worth $6 billion ...

Me, once valued at $6 billion, is now a penny stock. Layoffs, data breaches, and resignations led to its downfall. How did it ...

23andMe CEO Anne Wojcicki and New Mountain Capital have submitted a proposal to take the embattled genetic testing company private, according to a Friday filing with the U.S. Securities and ...

23andMe ME1.34%increase; green up pointing triangle rejected its chief executive’s proposal to buy back the company at 41 cents a share as the struggling company explores strategic alternatives ...

Anna Wojcicki, the CEO of DNA testing app 23andMe that was sold for $6billion, is trying to buy the company back for just $75million. The troubled company was worth billions six years ago but now ...

23andMe's big push into drug development, announced with great fanfare almost a decade ago, has ended with a whimper and sweeping job losses. The company that made its name by providing saliva ...

Genetic testing specialist 23andMe has launched a strategic review that could result in a sale of the company, after months of speculation about its future. The company's board has formed a ...

When evaluating 23andMe's stock performance and future outlook, investors should consider short-term market trends and long-term growth potential. This analysis will dive into recent stock metrics ...

SUNNYVALE, Calif., March 03, 2025 (GLOBE NEWSWIRE) -- The Special Committee of the Board of Directors of 23andMe Holding Co. (“23andMe” or the “Company”) (Nasdaq: ME) today confirmed receipt of a ...

The special committee of the board of directors of 23andMe (ME) confirmed receipt of a non-binding proposal from Anne Wojcicki, CEO, ...